Zenith Epigenetics Corp

About Zenith Epigenetics Corp

Zenith Epigenetics is a clinical stage biotechnology company with a broad and deep drug discovery platform in epigenetics, developing orally active, small molecules that are selective for inhibition of BET bromodomains. This platform integrates structural biology, modeling, medicinal chemistry with biochemical and cell-based assays to discover potent compounds which are then further evaluated for desirable pharmaceutical properties, including oral bioavailability, and in animal models of disease. Through ongoing discovery activities we are continuing to secure intellectual property around novel compounds and their analogs.

YEAR FOUNDED:

2013

LEADERSHIP:

CEO: Donald J. McCaffrey

CBO: Sanjay Lakhotia

CFO: A. Brad Cann

JOBS:

Please click here for Zenith Epigenetics job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.